K. H. Kim

Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer

K. Rha, K. Koo, S. Hong, 2015, Yonsei medical journal.

Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)

S. Hong, K. H. Kim, Kyung Seok Han, 2015, BMC Cancer.

Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels

K. Rha, K. Koo, S. Hong, 2015, Prostate international.

Prognostic impact of synchronous second primary malignancies on the overall survival of patients with metastatic prostate cancer.

K. Rha, K. Koo, S. Hong, 2015, The Journal of urology.

The prognostic effect of prostate-specific antigen half-life at the first follow-up visit in newly diagnosed metastatic prostate cancer.

Y. Choi, K. Rha, D. K. Kim, 2015, Urologic oncology.

Single Positive Lymph Node Prostate Cancer Can Be Treated Surgically without Recurrence

Y. Choi, K. Rha, D. K. Kim, 2016, PloS one.